More
    Guided Solutions - Connecting Talent With Innovation/div>

    Francis Medical raises $80M Series C for water vapor ablation tech

    Francis Medical completed an oversubscribed $80 million Series C equity financing. Arboretum Ventures and Solas BioVentures co-led the Series C round. New investors Orlando...

    CeQur raises $120M financing to support insulin delivery tech

    CeQur closed a $120 million financing round to support its wearable insulin delivery technology. Horw, Switzerland-based CeQur plans to use the funds to drive growth...

    FIRE1 raises $120M for breakthrough heart failure management tech

    FIRE1 completed a $120 million financing round to accelerate the advancement of its heart failure management system. The company also reached a major FDA...

    Microbot Medical announces $7m offering for surgical robot commercialisation

    Microbot Medical entered into definitive agreements for the purchase and sale of common stock for proceeds of $7 million. The offering includes just over...

    Axial3D secures $18m in equity funding

    A Belfast-based medical tech firm which specialises in creating AI-powered 3D medical imaging algorithms and other 3D solutions has finalised a fresh multi-million pound...

    Precision Neuroscience raises $102M to support BCI

    Brain-computer interface (BCI) maker Precision Neuroscience announced it closed a Series C funding round worth $102 million. General Equity Holdings led the financing round,...

    Flow Medical secures $2m to advance breakthrough thrombolysis catheter for pulmonary embolism treatment

    Flow Medical has closed a $5 million oversubscribed seed round, the thrombolysis catheter developer announced. The round includes a previously reported $2 million from...

    Fluid Biomed raises $27m to advance ReSolv brain aneurysm stent

    Fluid Biomed has completed a $27m Series A equity financing round to advance the development of its stent for treating brain aneurysms. The Canada-based company...

    ENEA-Tech Biomedical foundation invests €6m in BetaGlue Therapeutics

    BetaGlue® Therapeutics S.p.A. (“BetaGlue”) an Italian clinical-stage oncology company developing an innovative radiotherapy platform for the targeted and personalised treatment of unresectable solid tumours,...

    Latest articles